The Law Office of Joseph Klein is investigating the Board of Directors of Martek Biosciences Corporation (“Martek”) (NasdaqGS: MATK) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to Royal DSM N.V. (NYSE: DSM). Under the terms of the proposed transaction, Martek stockholders will receive $31.50 in cash for each outstanding share of Martek stock they own for a total transaction value of approximately $1.09 billion.

The investigation concerns whether the Martek Board of Directors breached their fiduciary duties to Martek stockholders by failing to adequately shop the Company before entering into this transaction and whether Royal DSM is underpaying for Martek shares.

If you own common stock in Compellent and wish to obtain additional information, please contact Joseph Klein, Esq. directly, via email at jk@jkleinlawfirm.com, by telephone at 718-947-0005, Toll Free: 877-STOK-180, or visit http://www.jkleinlawfirm.com/martekbiosciences.html.

Joseph Klein, Esq. is an experienced attorney and has also practiced as a Certified Public Accountant. Mr. Klein represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

Copyright Business Wire 2010